WATSON 425 (Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg)
Pill imprint WATSON 425 has been identified as Aspirin, butalbital, caffeine and codeine phosphate 325 mg / 50 mg / 40 mg / 30 mg.
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 425
- Strength:
- 325 mg / 50 mg / 40 mg / 30 mg
- Color:
- Blue & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Manufacturer:
- Watson Pharmaceuticals
More about aspirin/butalbital/caffeine/codeine
Consumer resources
- Aspirin/butalbital/caffeine/codeine
- Aspirin, butalbital, caffeine, and codeine
- Butalbital, aspirin, caffeine, and codeine (Advanced Reading)
- Other brands: Fiorinal with Codeine, Ascomp with Codeine, Fiorinal with Codeine III
Professional resources
- Butalbital,Aspirin,Caffeine,Codeine (FDA)
- Butalbital, Aspirin, Caffeine, and Codeine (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
